Kobayashi, C., Suzuki‐Imaizumi, M., Sakaguchi, Y., Ishii, T., Adachi, M., Kaneda, A., . . . Mori, K. (2024). The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti‐PD‐1 antibody and paclitaxel. Wiley. https://doi.org/10.1111/cas.16366
Citazione stile Chigago Style (17a edizione)Kobayashi, Chiaki, et al. The Novel and Potent CD40 Agonist KHK2840 Augments the Antitumor Efficacy of Anti‐PD‐1 Antibody and Paclitaxel. Wiley, 2024. https://doi.org/10.1111/cas.16366.
Citatione MLA (9a ed.)Kobayashi, Chiaki, et al. The Novel and Potent CD40 Agonist KHK2840 Augments the Antitumor Efficacy of Anti‐PD‐1 Antibody and Paclitaxel. Wiley, 2024. https://doi.org/10.1111/cas.16366.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.